Two biotech startups, RenBio and Fractyl Health, are exploring innovative ways to help the body produce more GLP-1, a hormone that plays a crucial role in regulating appetite and blood sugar levels. Their goal is to develop gene therapies that can turn cells into tiny factories producing GLP-1, potentially offering a long-lasting solution for weight loss and diabetes...
More and more people are using weight loss drugs through their jobs. But these drugs are expensive. This is causing big problems for employers. Big companies are more likely to cover these drugs. 43% of large firms now offer this benefit. That's up from 28% last year. But smaller companies are not following suit. Only 16% of firms with 200 to 999 workers cover weigh...
Employers are bracing for a significant hike in health care costs next year, with a median increase of 9 percent expected. This trend is largely driven by the rising use of GLP-1 drugs for obesity and diabetes, as well as the increasing prevalence and cost of cancer treatments. The survey, which included 121 employers covering 11. 6 million people, highlights the gro...
People are talking about weight loss drugs on social media. These drugs, known as GLP-1 RAs, are popular. But what are people saying about them? Are they talking about side effects? Both short-term and long-term ones? What about side effects that happen together? These are important questions. Social media is a big place. It's where people share their experiences. F...
Polycystic ovary syndrome (PCOS) is a common but often misunderstood condition affecting millions of women. It can cause a range of symptoms, from irregular periods and weight gain to infertility and mental health struggles. For years, treatments have been limited, but a new class of drugs originally designed for weight loss and diabetes might offer some relief. Gra...
People often think that taking a pill can fix everything. But when it comes to managing weight and health, it's not that simple. GLP-1 drugs, which help with weight loss, are popular. But they're not magic. They work better when combined with good food choices and regular exercise. First, let's talk about food. Eating healthy isn't about strict diets. It's about mak...
People with type 2 diabetes often take special medicines. Two of these are GLP-1 receptor agonists and SGLT2 inhibitors. Both help control blood sugar. But do they affect the risk of leg amputations differently? A big study looked at this question. It compared new users of these two types of drugs. The goal was to see if one group had more leg amputations than the o...
Semaglutide, the key component in Ozempic and Wegovy, might offer more than just weight loss and diabetes management. Recent research suggests it could also lower dementia risk in type 2 diabetes patients. Scientists from Case Western Reserve University discovered this link, publishing their findings in the Journal of Alzheimer’s Disease. The study analyzed medical ...
People who are overweight or obese often try different treatments to manage their weight. One such treatment involves medicines that mimic natural hormones in the body. These hormones, like GLP-1 and GIP, help control blood sugar and appetite. A recent study looked at how these medicines affect taste and hunger. It found that people taking these medicines often noti...
Bodybuilders are known for pushing boundaries, especially when it comes to enhancing their physiques. Recently, they have been experimenting with GLP-1 medicines. These drugs, like Semaglutide and Tirzepatide, were originally designed to manage diabetes. However, they have gained attention for their weight loss benefits. This has led to a rise in off-label use, meani...